Injectable Drug Delivery Devices Market is Anticipated to Increase at a CAGR of 11.25% and will touch USD 33.37 billion by 2026, States DelveInsight

LAS VEGAS, Oct. 5, 2021 /PRNewswire/ -- According to the latest report published by DelveInsight, "Injectable Drug Delivery Devices Market & Competitive Landscape" will provide in-depth market understanding for Injectable Drug Delivery Devices Market, which will further benefit the competitors or stakeholders operating in the Injectable Drug Delivery Devices market arena. 

DelveInsight_Logo

Curious to unearth how the Injectable Drug Delivery Devices Market will be growing by 2026? Click to get a snapshot of Injectable Drug Delivery Devices Market Analysis

Injectable Drug Delivery Devices Overview

Injectable Drug Delivery Devices comprise auto-injectors and needle-free injectors, among others. Furthermore, the increase in many disorders such as Wilson's disease, hepatitis C, autoimmune diseases, and cystic fibrosis, among others, involve the use of injectables to deliver medications. Needleless injectors tend to reduce pain during drug delivery and confine medications evenly in the dermis area. Various needle-free intradermal injections using corticosteroids and/or local anesthetics are in the developmental phase for several indications. These factors can increase the demand for drug delivery devices, further increasing the Injectable Drug Delivery Devices market.

Injectable Drug Delivery Devices Market Insight

Geographically, the global Injectable Drug Delivery Devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. North America currently leads the global market in terms of revenue share and is anticipated to remain constant during the forecast period. Nevertheless, the supremacy of North America will be conspicuously challenged by the European market. This domination is attributed to the large population base afflicted with several disorders and their complications, and the high adoption of injectable drug delivery devices in the United States. There are great opportunities for Injectable Drug Delivery Devices market penetration for countries like Mexico, India, and China to the major companies already having a grip in developed regions. 

Request Injectable Drug Delivery Devices Market Report to learn more about trends in specific geographies @ Injectable Drug Delivery Devices Market Trends 

COVID-19 Impact Analysis on Injectable Drug Delivery Devices Market 

The market for Injectable Drug Delivery Devices observed a period of growth due to the outbreak of COVID-19. Due to the pandemic, there was a rise in the development of advanced injectable drug delivery devices to deliver the required drug in the body. Hence, there was no restraint witnessed on the growth of Injectable Drug Delivery Devices. The market for Injectable Drug Delivery Devices is anticipated to increase during Covid-19 and post it. Various companies were involved in the research and development of Injectable Drug Delivery Devices after Covid 19. On April 27, 2021, PharmaJet had presented the needle-free delivery of Covid-19 DNA vaccine results at the World Vaccine Congress

Furthermore, the global Injectable Drug Delivery Devices market by product type is categorized into the Self-Injectors, Needle-Free, Auto-Injectors, Wearable Injectors, and Insulin Pens. Various technological advancements offered by these devices consist of convenient patient use and are available at a low cost. The latest generation needle-free injections are patient-oriented, easy-to-use, and disposable, and their use can be anticipated to expand dramatically over the coming years. Due to these technological advancements observed in needle-free injectors in contrast to other devices, there will be an increase in the demand for the Injectable Drug Delivery Devices market, thereby leading to a boost in the injectable drug delivery market. Various collaborations and mergers are also expected to drive the injectable drug delivery market; for instance, on November 13, 2019, Stevanto Group and Duoject Medical Systems had an exclusive partnership to provide pharmaceutical clients with an emergency-use auto-injector.

Injectable Drug Delivery Devices Market Report Scope

  • Study Period: 2018-2026
  • Key Companies: Eli Lilly and Company, Biocon, Becton, Dickinson & Company, West Pharmaceutical Services, Inc., Johnson & Johnson, Antares Pharma, and others.
  • Segmentation: By Reusability, By On-Site Delivery, By End-User, By Product Type, By Drug Loading, and By Geography
  • By Product Type
    • Self-Injectors
    • Needle-Free
    • Auto-Injectors
    • Wearable Injectors
    • Insulin Pens
  • By On-Site Delivery
    • Intramuscular
    • Intradermal
    • Subcutaneous
  • By Reusability
    • Disposable
    • Reusable
  • By End-User
    • Hospitals
    • Specialty Clinics
    • Homecare Settings
  • By Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of World

Table of Contents

1

Injectable Drug Delivery Devices Report Introduction

2

Injectable Drug Delivery Devices Market Executive Summary

1.  Scope of the Study

2.  Market at Glance

3.  Competitive Assessment

4.  Financial Benchmarking

3

Regulatory and Patent Analysis

5.  The United States

6.  Europe

1.  Germany

2.  France

3.  Italy 

4.  Spain 

5.  The U.K.

7.  Japan

4

Injectable Drug Delivery Devices Market Key Factors Analysis

1.  Injectable Drug Delivery Devices Market Drivers

1.  Increasing incidences of chronic conditions such as cancer, diabetes, and cardiovascular disorders, among others

2.  Increase in demand for self-injectors

3.  Increase in biologics and biosimilar market

4.  Rising need and demand for patient compliance to treatment

5.  Rising innovations and technological advancement

2.  Injectable Drug Delivery Devices Market Restraints and Challenges

1.  Certain side effects caused due to the nanoparticles of the drug delivery system

2.  High costs associated with advanced injectable drug delivery devices are expected to limit the market growth over the forecast period

3.  Injectable Drug Delivery Devices Market Opportunities 

1.  The increasing awareness among elderly people has also increased the demand for connected injectable drug delivery devices

2.  Rising demand for disposable injecting devices and prefilled syringes

5

Injectable Drug Delivery Devices Porter's Five Forces Analysis

5.1 Bargaining Power of Suppliers

5.2 Bargaining Power of Consumers

5.3 Threat of New Entrants

5.4 Threat of Substitutes 

5.5 Competitive Rivalry

6

COVID-19 Impact Analysis on Injectable Drug Delivery Devices Market

7

Injectable Drug Delivery Devices Market layout

7.1 By Reusability

7.1.1 Reusable Devices

7.1.2 Disposable Devices

7.2 By On-Site Delivery

7.2.1 Intramuscular

7.2.2 Intradermal

7.2.3 Subcutaneous

7.3 By Product Type

7.3.1 Self-injectors

7.3.2 Needle-free Injectors

7.3.3 Auto-Injectors

7.3.4 Wearable Injectors

7.3.5 Insulin Pens

7.4 By Drug Loading

7.4.1 Prefilled devices

7.4.2 Fillable Devices

7.5 By End User

7.5.1 Hospitals

7.5.2 Specialty Clinics 

7.5.3 Home care settings

7.6 By Geography

7.6.1 North America

7.6.2 Europe

7.6.3 Asia-Pacific

7.6.4 Rest of the World (RoW)

8

Injectable Drug Delivery Devices Global Company Share Analysis – Key 3-5 Companies

9

Injectable Drug Delivery Devices Company and Product Profiles

9.1 Eli Lilly and Company 

9.2  Biocon

9.3  Becton, Dickinson & Company

9.4  West Pharmaceutical Services, Inc.

9.5  Johnson & Johnson

9.6  Antares Pharma

9.7  AbbVie Inc.

9.8  Pfizer Inc. 

9.9  Mylan N.V.

9.10  Vetter Pharma-Fertigung GmbH & Co.KG

9.11  Emperra GmbH

9.12  Gerresheimer AG

9.13  SCHOTT AG

9.14  Terumo Corporation

9.15  Teva Pharmaceutical Industries Ltd

10

Project Approach

11

KOL Views

12

DelveInsight Capabilities

13

Disclaimer

14

About DelveInsight

Related Reports

  • Needle Free Injections Market 

DelveInsight's 'Needle Free Injections Market Insights, Competitive Landscape and Market Forecast-2026' report delivers an in-depth understanding of Needle Free Injections and Competitive Landscape analysis. Key companies such as Antares Pharma, Inc., Endo International plc, PharmaJet, Bioject Medical Technologies Inc., Medical International Technology, Inc., INJEX Pharma AG, National Medical Products Inc., and others are working in this domain. 

  • Ultra-Large Volume Wearable Injectors Market

DelveInsight's 'Ultra-Large Volume Wearable Injectors -Market Insights, Competitive Landscape and Market Forecast - 2026' report delivers an in-depth understanding and Competitive Landscape analysis. Key companies such as Gerresheimer AG, Enable Injections, Amgen Inc, Insulet Corporation, West Pharmaceutical Services, Inc., and others are working in this domain. 

  • 3D Cardiac Mapping System Market

DelveInsight's '3D Cardiac Mapping System -Market Insights, Competitive Landscape and Market Forecast - 2026' report delivers an in-depth understanding of the 3D Cardiac Mapping System and Competitive Landscape analysis. Key companies such as Biosense Webster, Inc., Boston Scientific Corporation, Inc., Abbott, Kardium, Inc, Medtronic, and others are working in this domain. 

  • Germ Cell Tumor Market

DelveInsight's Germ Cell Tumor Market Insights, Epidemiology and Market Forecast - 2030 report provides a detailed overview of the disease and a depth understanding of historical and forecasted epidemiology. 

  • Glycogen Storage Disease Market

DelveInsight's Glycogen Storage Disease Market Insights, Epidemiology and Market Forecast - 2030 report provided a detailed overview of the disease and in-depth understanding and forecasted epidemiology. 

Browse Blog Posts

  • Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the IgA Nephropathy Market Share Growth
  • Essential Demands Impinge the Evolving Adult-onset Still's Disease Treatment Market
  • Follicular Lymphoma Market Size Anticipates Growth as the Key Companies Explores Novel Therapeutics Assets

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also provides Business Consulting Services with a credible market analysis that will help accelerate the business growth and overcome challenges with a practical approach. 

Contact Us:

Shruti Thakur
info@delveinsight.com   
+1(919)321-6187
www.delveinsight.com 

Cision View original content:https://www.prnewswire.com/news-releases/injectable-drug-delivery-devices-market-is-anticipated-to-increase-at-a-cagr-of-11-25-and-will-touch-usd-33-37-billion-by-2026--states-delveinsight-301393021.html

SOURCE DelveInsight Business Research, LLP

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.